SARS-CoV-2 Vaccination and Severe COVID-19 Infection and Reinfection Outcomes among Patients with ESKD from a National Dialysis Provider
Kidney360
.
2024 Aug 1;5(8):1186-1190.
doi: 10.34067/KID.0000000000000494.
Epub 2024 Jul 8.
Authors
Monica M Shieu
1
,
Nien Chen Li
1
,
Harold J Manley
1
,
Antonia Harford
1
,
Caroline M Hsu
2
,
Daniel E Weiner
2
,
Dana Miskulin
2
,
Doug Johnson
1
,
Eduardo K Lacson Jr
1
2
Affiliations
1
Dialysis Clinic Inc., Nashville, Tennessee.
2
Tufts Medical Center, Boston, Massachusetts.
PMID:
39752238
PMCID:
PMC11371339
DOI:
10.34067/KID.0000000000000494
No abstract available